1. Home
  2. LFVN vs KPTI Comparison

LFVN vs KPTI Comparison

Compare LFVN & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

N/A

Current Price

$6.32

Market Cap

78.0M

Sector

Health Care

ML Signal

N/A

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$0.88

Market Cap

36.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFVN
KPTI
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
36.7M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
LFVN
KPTI
Price
$6.32
$0.88
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
★ $7.50
$7.25
AVG Volume (30 Days)
33.8K
★ 1.2M
Earning Date
11-03-2026
11-02-2026
Dividend Yield
★ 3.17%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.40
N/A
Revenue
★ $203,204,000.00
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.34
$27.98
P/E Ratio
$15.80
★ N/A
Revenue Growth
★ 1.86
0.57
52 Week Low
$3.90
$1.20
52 Week High
$11.71
$10.99

Technical Indicators

Market Signals
Indicator
LFVN
KPTI
Relative Strength Index (RSI) 48.79 23.57
Support Level $6.26 N/A
Resistance Level $6.51 $2.16
Average True Range (ATR) 0.21 0.16
MACD 0.02 0.04
Stochastic Oscillator 53.71 0.00

Price Performance

Historical Comparison
LFVN
KPTI

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: